National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

samarium Sm 153 lexidronam pentasodium
The pentasodium salt of samarium Sm 135 lexidronam, a therapeutic agent consisting of a medium energy beta- and gamma-emitting radioisotope, samarium Sm 135, and a teraphosphonate chelator, ethylenediaminetetramethylene phosphonic acid (EDTMP). The chelator moiety of samarium Sm 153 lexidronam associates with hydroxyapatite crystals concentrated in areas of bone turnover, thereby selectively delivering samarium Sm 153-mediated cytotoxic radiation to osteoblastic bone metastases. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:samarium Sm 153 lexidronam
Samarium-153 EDTMP
Sm 153 lexidronam pentasodium
Sm-153 EDTMP
US brand name:Quadramet
Abbreviations:153Sm-EDTMP
Sm-153 EDTMP



Previous:Salagen, salinosporamide A, salirasib, salmonella VNP20009, Salvia officinalis extract tablet
Next:Sandimmun, Sandimmune, Sandoglobulin, Sandostatin, Sandostatin Lar Depot

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov